Literature DB >> 32693409

Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.

Rina Nishii1, Rebekah Baskin-Doerfler2, Wentao Yang1, Ninad Oak2, Xujie Zhao1, Wenjian Yang1, Keito Hoshitsuki1, Mackenzie Bloom2, Katherine Verbist2, Melissa Burns3,4, Zhenhua Li5, Ting-Nien Lin1, Maoxiang Qian1,6,7, Takaya Moriyama1, Julie M Gastier-Foster8,9,10, Karen R Rabin11, Elizabeth Raetz12, Charles Mullighan9,13, Ching-Hon Pui2,13, Allen Eng-Juh Yeoh14,15,16, Jinghui Zhang17, Monika L Metzger13,18, Jeffery M Klco9,13, Stephen P Hunger19, Scott Newman17, Gang Wu17, Mignon L Loh20,21, Kim E Nichols2,13, Jun J Yang1,2,13.   

Abstract

There is growing evidence supporting an inherited basis for susceptibility to acute lymphoblastic leukemia (ALL) in children. In particular, we and others reported recurrent germline ETV6 variants linked to ALL risk, which collectively represent a novel leukemia predisposition syndrome. To understand the influence of ETV6 variation on ALL pathogenesis, we comprehensively characterized a cohort of 32 childhood leukemia cases arising from this rare syndrome. Of 34 nonsynonymous germline ETV6 variants in ALL, we identified 22 variants with impaired transcription repressor activity, loss of DNA binding, and altered nuclear localization. Missense variants retained dimerization with wild-type ETV6 with potentially dominant-negative effects. Whole-transcriptome and whole-genome sequencing of this cohort of leukemia cases revealed a profound influence of germline ETV6 variants on leukemia transcriptional landscape, with distinct ALL subsets invoking unique patterns of somatic cooperating mutations. 70% of ALL cases with damaging germline ETV6 variants exhibited hyperdiploid karyotype with characteristic recurrent mutations in NRAS, KRAS, and PTPN11. In contrast, the remaining 30% cases had a diploid leukemia genome and an exceedingly high frequency of somatic copy-number loss of PAX5 and ETV6, with a gene expression pattern that strikingly mirrored that of ALL with somatic ETV6-RUNX1 fusion. Two ETV6 germline variants gave rise to both acute myeloid leukemia and ALL, with lineage-specific genetic lesions in the leukemia genomes. ETV6 variants compromise its tumor suppressor activity in vitro with specific molecular targets identified by assay for transposase-accessible chromatin sequencing profiling. ETV6-mediated ALL predisposition exemplifies the intricate interactions between inherited and acquired genomic variations in leukemia pathogenesis.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32693409      PMCID: PMC7819760          DOI: 10.1182/blood.2020006164

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  8 in total

Review 1.  Genetics of inherited thrombocytopenias.

Authors:  Julia T Warren; Jorge Di Paola
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

Review 2.  Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children.

Authors:  Oskar A Haas; Arndt Borkhardt
Journal:  Leukemia       Date:  2022-10-20       Impact factor: 12.883

3.  Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.

Authors:  Zhenhua Li; Shawn Hsien Ren Lee; Winnie Hui Ni Chin; Yi Lu; Nan Jiang; Evelyn Huizi Lim; Elaine Coustan-Smith; Kean Hui Chiew; Bernice Ling Zhi Oh; Grace Shimin Koh; Zhiwei Chen; Shirley Kow Yin Kham; Thuan Chong Quah; Hai Peng Lin; Ah Moy Tan; Hany Ariffin; Jun J Yang; Allen Eng-Juh Yeoh
Journal:  Blood Adv       Date:  2021-12-14

Review 4.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

Review 5.  In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.

Authors:  Nadine Rüchel; Vera H Jepsen; Daniel Hein; Ute Fischer; Arndt Borkhardt; Katharina L Gössling
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

6.  ETV6-related thrombocytopenia: dominant negative effect of mutations as common pathogenic mechanism.

Authors:  Michela Faleschini; Daniele Ammeti; Nicole Papa; Caterina Alfano; Roberta Bottega; Giorgia Fontana; Valeria Capaci; Melania E Zanchetta; Federico Pozzani; Francesca Montanari; Valeria Petroni; Paola Giordano; Patrizia Noris; Fiorina Giona; Anna Savoia
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

7.  Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate.

Authors:  Ismail Siti Mariam; Ramli Norhidayah; Abu Bakar Zulaikha; Mohd Yunus Nazihah; Hassan Rosline; Ghazali Anis Kausar; Sulong Sarina; Husin Azlan; Ravindran Ankathil
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

8.  Construction of a prognostic model related to copper dependence in breast cancer by single-cell sequencing analysis.

Authors:  Xiao Guan; Na Lu; Jianping Zhang
Journal:  Front Genet       Date:  2022-08-23       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.